Profile data is unavailable for this security.
About the company
Gensight Biologics SA is a France-based biopharmaceutical company. The Company develops and commercializes gene therapy-based treatments of retinal degenerative diseases. It develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The Company intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).
- Revenue in EUR (TTM)194.00k
- Net income in EUR-15.12m
- Incorporated2012
- Employees13.00
- LocationGensight Biologics SA74 Rue du Faubourg Saint-AntoinePARIS 75012FranceFRA
- Phone+33 176217220
- Fax+33 176217221
- Websitehttps://www.gensight-biologics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Genomics SA | 0.00 | -8.89m | 5.03m | 2.00 | -- | -- | -- | -- | -0.1276 | -0.1276 | 0.00 | -0.0352 | 0.00 | -- | -- | 0.00 | -433.64 | -70.24 | -858.41 | -123.45 | -- | -3,200.37 | -- | -3,364.53 | -- | -131.86 | 14.44 | -- | -100.00 | -- | -180.44 | -- | -- | -- |
| Plant Advanced Technologies PAT SA | 941.74k | 318.01k | 9.42m | 16.00 | 30.26 | 1.00 | 10.67 | 10.01 | 0.2776 | 0.2776 | 0.8377 | 8.38 | -- | -- | -- | 58,858.75 | -- | -1.51 | -- | -1.96 | 144.97 | 128.32 | 33.77 | -13.36 | 0.3156 | -- | 0.2867 | -- | 14.61 | 10.44 | 1,081.17 | -- | -- | -- |
| Oncodesign Precision Medicine Opm SA | 207.25k | 6.27m | 10.32m | 13.00 | 1.61 | 0.9735 | 1.58 | 49.80 | 0.3457 | 0.3457 | 0.0114 | 0.5732 | 0.0119 | -- | 0.2634 | 11,513.89 | 36.11 | -- | 54.21 | -- | 6,372.89 | -- | 3,026.21 | -- | 0.926 | 20.81 | 0.3859 | -- | -80.69 | -- | 10.89 | -- | -- | -- |
| Predilife SA | 728.07k | -3.80m | 12.62m | 27.00 | -- | -- | -- | 17.33 | -0.9936 | -0.9936 | 0.1905 | -1.26 | 0.3919 | -- | 3.63 | 36,421.71 | -204.34 | -93.24 | -- | -132.80 | 98.10 | 89.32 | -521.48 | -1,377.00 | -- | -19.99 | -- | -- | 55.20 | 84.82 | -0.9621 | -- | -24.35 | -- |
| Nfl Biosciences SAS | 0.00 | -3.15m | 14.80m | 4.00 | -- | 4.33 | -- | -- | -0.2779 | -0.2779 | 0.00 | 0.2699 | 0.00 | -- | -- | 0.00 | -66.86 | -75.08 | -91.01 | -121.22 | -- | -- | -- | -- | -- | -- | 0.0088 | -- | -- | -- | 44.44 | -- | -- | -- |
| Poxel SA | 7.66m | -13.66m | 15.70m | 5.00 | -- | -- | -- | 2.05 | -0.2594 | -0.2594 | 0.1443 | -1.14 | 1.45 | -- | 8.90 | 1,276,167.00 | -258.08 | -69.11 | -- | -133.51 | 52.02 | 80.83 | -178.45 | -475.98 | -- | -0.1862 | -- | -- | 234.98 | -24.22 | 47.83 | -- | -- | -- |
| Gensight Biologics SA | 194.00k | -15.12m | 17.52m | 13.00 | -- | -- | -- | 90.29 | -0.1293 | -0.1293 | 0.0016 | -0.245 | 0.0174 | -- | 10.78 | 16,166.67 | -135.38 | -81.19 | -- | -203.71 | -- | -- | -7,793.81 | -868.76 | -- | -- | -- | -- | 18.39 | 16.47 | 46.60 | -- | -57.94 | -- |
| Valbiotis SA | 472.00k | -11.12m | 26.54m | 44.00 | -- | 2.25 | -- | 56.23 | -0.6994 | -0.6994 | 0.0297 | 0.4967 | 0.0206 | 1.57 | 4.89 | 10,727.27 | -48.58 | -33.12 | -61.97 | -47.09 | -603.81 | 19.74 | -2,354.87 | -464.77 | 2.93 | -74.38 | 0.3129 | -- | -96.30 | 13.97 | -36.06 | -- | -2.02 | -- |
| Novacyt SA | 21.95m | -31.90m | 27.73m | 234.00 | -- | 0.5902 | -- | 1.26 | -0.4519 | -0.4949 | 0.3112 | 0.6652 | 0.2354 | 2.34 | 5.27 | 93,804.38 | -34.20 | 5.59 | -39.09 | 7.29 | 63.35 | 66.74 | -145.32 | 9.83 | 4.59 | -7.23 | 0.2114 | -- | 84.82 | 11.35 | -60.50 | -- | 55.60 | -- |
| genOway SA | 20.95m | 1.29m | 30.49m | 148.00 | 16.14 | 1.13 | 7.54 | 1.46 | 0.1487 | 0.1487 | 2.42 | 2.12 | 0.594 | 0.8797 | 3.69 | 146,514.10 | 3.65 | 2.10 | 4.72 | 2.91 | 94.91 | 94.80 | 6.14 | 3.76 | 2.21 | -- | 0.4407 | -- | 10.04 | 18.46 | 16.79 | -- | 15.88 | -- |
| Theranexus SA | 0.00 | -2.94m | 31.87m | 10.00 | -- | -- | -- | -- | -0.3641 | -0.3641 | 0.00 | -0.1923 | 0.00 | -- | -- | 0.00 | -66.82 | -44.47 | -148.89 | -50.85 | -- | -- | -- | -- | -- | -37.71 | 2.90 | -- | -- | -- | 74.15 | -- | -56.53 | -- |
| Fermentalg SA | 12.78m | -11.54m | 36.88m | 63.00 | -- | 1.30 | -- | 2.89 | -0.1242 | -0.1242 | 0.1353 | 0.3156 | 0.2472 | 7.91 | 3.29 | 199,734.40 | -17.09 | -18.10 | -21.17 | -20.59 | 20.94 | 25.51 | -69.14 | -147.66 | 1.83 | -- | 0.2368 | -- | 183.32 | 43.52 | 8.99 | -- | -4.91 | -- |
Data as of Feb 10 2026. Currency figures normalised to Gensight Biologics SA's reporting currency: Euro EUR
8.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Heights Capital Management, Inc.as of 08 Jan 2025 | 12.01m | 6.31% |
| Armistice Capital LLCas of 18 Sep 2024 | 3.66m | 1.92% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 254.66k | 0.13% |
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
